Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Gyrodyne , LLC GYRO

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy
Sell
Insider Ownership
0.00%

Capital & Financial Ratios

Market Cap
11.06
Revenue
1.59
Net Income
0.00
Free Cash Flow
(2.81)
Net Debt
4.54
Current Ratio
1.78
Debt/Equity
0.37
P/E ratio
0.00
P/S ratio
4.64
P/B ratio
0.29
Past 5Y EPS Growth
This Y EPS Growth
Next Y EPS Growth
Next 5Y EPS Growth
in millions of $

Dividends

Payout Ratio
0.00
Annual Dividend Rate
Annual Dividend Yield

Assets vs Liabilities

2021 2022 2023 Q'24
Cash 5.67 4.08 3.49 6.70
Receivables 0.07 0.14 0.13 0.18
Inventory
Other
5.74 4.22 3.62 6.88
2021 2022 2023 Q'24
Payables 1.15 1.45 2.64 1.92
ST’ Debt
Other
2.09 2.73 4.34 3.87
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡ ‡‡‡
Earnings ‡‡‡ ‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Year
in millions of $

Operating Cash Flow

Year
in millions of $

Free Cash Flow

Year
in millions of $

EPS

Year

Target Price Range

High
Average
Low

Recommendation Rating

1
Buy
2
3
Hold
4
5
Sell
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ 8.10 7.80
Low Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 14.87 12.66
High Price
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 4 4
Employees
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 0.00 0.00
Revenue/Emp
Revenue
Gross Margin
EBT
EBT Margin
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 0.00 0.00
Net Income
Depreciation
Revenue/Sh
Earnings/Sh
Cash Flow/Sh
Capex/Sh
Free CF/Sh
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 0.00 0.00
Book Value/Sh
Shares
PE Ratio
PS Ratio
PB Ratio
EV/Sales
EV/FCF
Op' Cash Flow
Capex
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.49 (0.71)
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.76 10.98
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.68 7.49
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 30.37 30.72
Sh' Equity
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 0.00% 0.00%
ROA
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 0.00% 0.00%
ROIC
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Gyrodyne, LLC (GYRO), a small-cap REIT specializing in Long Island industrial and office properties, exemplifies asset-heavy stagnation amid commercial real estate headwinds like post-2008 slowdowns, COVID-driven office vacancies, and 2022 interest rate hikes. Over the past decade, its stock has eroded 61-73% from 2016 highs, stabilizing near recent lows with no revenue, zero net income, and a skeletal staff of four employees since 2017—operating more as a wind-down holding company following a 2017 strategic review and key property sales.

Balance sheet strains underscore the distress: shareholder equity grew modestly to $30.7 million by 2023, but debt exploded 899% to $11 million, flipping net debt positive by $7.5 million and turning working capital negative at -$0.71 million. Zero profitability metrics (ROA/ROIC at 0%) and recent insider sells totaling $50,000—without any buys—signal eroding confidence, decoupling GYRO from thriving REIT peers amid illiquid assets and rising leverage risks.

With no analyst coverage or forward projections, the outlook points to a liquidation grind: modest NAV realization possible via asset sales, but mounting debt and operational void cap upside, potentially testing new lows if rates persist. Investors face a classic value trap demanding vigilance on refinancing or special dividends.

Gyrodyne , LLC (GYRO) Latest News

News by impact score

Fine-tune

17 Oct

4 GlobeNewswire, 4:20 PM
Gyrodyne, LLC has entered into an agreement with Star Equity Fund, which is expected to enhance the company's financial position and strategic initiatives. The partnership aims to leverage Star Equity's resources and expertise to support Gyrodyne's growth objectives. This collaboration is anticipated to provide Gyrodyne with additional capital and operational support, potentially leading to improved market performance. The agreement with Star Equity Fund is likely to significantly impact Gyrodyne's future performance and strategic direction.

4 Aug

3 GlobeNewswire, 12:46 PM
Gyrodyne, LLC has announced an agreement to sell a 49-acre parcel of land in Smithtown, New York, as part of its strategic liquidation plan. This sale is aimed at optimizing the company's asset portfolio and enhancing shareholder value during the ongoing liquidation process. The sale of the land is a strategic move that may positively influence financial performance but is not expected to fundamentally alter the company's overall trajectory.

16 Oct

4 GlobeNewswire, 7:00 AM
New York Supreme Court ruled in favor of Gyrodyne, dismissing a petition seeking to vacate the Town of Smithtown Planning Board's approval of Gyrodyne's eight-lot subdivision of its Flowerfield property. The court ruling has a significant impact on Gyrodyne's future as it upholds the integrity of the subdivision approval process and enhances clarity for potential buyers.

8 Mar

4 GlobeNewswire, 5:07 PM
Gyrodyne, LLC successfully closed an oversubscribed rights offering, generating $5 million in gross proceeds. The successful rights offering and generation of $5 million in gross proceeds are significant for Gyrodyne's future financial position and strategic initiatives.

6 Feb

4 GlobeNewswire, 9:25 AM
Gyrodyne, LLC announces commencement of rights offering to raise up to $5 million through subscription period for existing shareholders. The rights offering and potential $5 million raise could significantly impact Gyrodyne's future financial position and strategic direction.

22 Jan

3 GlobeNewswire, 11:13 AM
Gyrodyne, LLC announces record date for proposed rights offering to raise up to $5 million. The rights offering could have a moderately noticeable influence on Gyrodyne's financial performance and strategic plans.

6 Sep

3 PR Newswire, 8:30 AM
Gyrodyne announces agreement with Star Equity Fund to implement incentive compensation enhancements. The agreement is expected to moderately influence Gyrodyne's future financial performance and shareholder alignment.

1 Aug

4 Business Wire, 4:30 PM
Gyrodyne appoints Jan Loeb to Board of Directors. Appointment of Jan Loeb to the Board is a significant strategic move that could impact Gyrodyne's future performance and investor sentiment.

21 Jun

4 GlobeNewswire, 8:30 AM
Star Equity Fund criticizes Gyrodyne Board for entrenchment tactics and lack of shareholder value creation. The potential impact of the Board's actions on Gyrodyne's future and market performance is significant, as it could lead to major changes in corporate governance and shareholder value.

© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us